SMMT: Summit Therapeutics Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
245 institutions reported holding $1.92B of Summit Therapeutics Inc. on Form 13F (223 the quarter before). 54 opened a new position and 33 sold out. Shares held by institutions: +19%.
| Largest holders | Shares | Value |
|---|---|---|
| BAKER BROS. ADVISORS LP | 32,786,348 | $477.70M |
| FMR LLC | 10,043,947 | $146.34M |
| STATE STREET CORP | 9,536,796 | $138.95M |
| BlackRock, Inc. | 9,529,041 | $138.84M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,734,484 | $83.55M |
| UBS Group AG | 5,233,798 | $76.26M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,042,190 | $73.46M |
| GOLDMAN SACHS GROUP INC | 4,513,399 | $65.76M |
| Point72 Asset Management, L.P. | 3,697,803 | $53.88M |
| GEODE CAPITAL MANAGEMENT, LLC | 3,427,263 | $49.95M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.